Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83 - Wikidata - awgldk - TriplyDB

Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83

Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83

http://www.wikidata.org/entity/Q36399744

about

The dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape.Genes involved in the balance between neuronal survival and death during inflammation CD83 modulates B cell function in vitro: increased IL-10 and reduced Ig secretion by CD83Tg B cells.Influence of dendritic cells on viral pathogenicity A Kinetic Study of CD83 Reveals an Upregulation and Higher Production of sCD83 in Lymphocytes from Pregnant Mice An increase of CD83+ dendritic cells ex vivo correlates with increased regulatory T cells in patients with active eosinophilic granulomatosis and polyangiitis.CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation.The transmembrane E3 ligase GRAIL ubiquitinates and degrades CD83 on CD4 T cells.Dendritic cell CD83 homotypic interactions regulate inflammation and promote mucosal homeostasis The expression and characterization of functionally active soluble CD83 by Pichia pastoris using high-density fermentation.CD83-stimulated monocytes suppress T-cell immune responses through production of prostaglandin E2.L Particles Transmit Viral Proteins from Herpes Simplex Virus 1-Infected Mature Dendritic Cells to Uninfected Bystander Cells, Inducing CD83 Downmodulation Dancing with the enemy: the interplay of herpes simplex virus with dendritic cells.The CD83 reporter mouse elucidates the activity of the CD83 promoter in B, T, and dendritic cell populations in vivo.Dendritic cell CD83: a therapeutic target or innocent bystander?Th-1 polarization is regulated by dendritic-cell comparison of MHC class I and class II antigens.Thymic CD4 T cell selection requires attenuation of March8-mediated MHCII turnover in cortical epithelial cells through CD83.Heat-induced reactivation of HSV-1 in latent mice: upregulation in the TG of CD83 and other immune response genes and their LAT-ICP0 locus.CD83 polymorphisms and cervical cancer risk.Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14+ Monocytes.Multiple interferon regulatory factor and NF-κB sites cooperate in mediating cell-type- and maturation-specific activation of the human CD83 promoter in dendritic cells.Phosphorylation of the HuR ligand APRIL by casein kinase 2 regulates CD83 expression.Herpes simplex virus type 1 induces CD83 degradation in mature dendritic cells with immediate-early kinetics via the cellular proteasome.Sex Bias in Pathogenesis of Autoimmune Neuroinflammation: Relevance for Dimethyl Fumarate Immunomodulatory/Anti-oxidant Action.Tolerogenic dendritic cells pulsed with enterobacterial extract suppress development of colitis in the severe combined immunodeficiency transfer model.The Major Immediate-Early Protein IE2 of Human Cytomegalovirus Is Sufficient to Induce Proteasomal Degradation of CD83 on Mature Dendritic Cells CD83 Modulates B Cell Activation and Germinal Center Responses.Thymic stromal lymphopoietin deficiency attenuates experimental autoimmune encephalomyelitis.Post-transcriptional regulation of CD83 expression by AUF1 proteins Soluble CD14 and CD83 from human neonatal antigen-presenting cells are inducible by commensal bacteria and suppress allergen-induced human neonatal Th2 differentiation.Inhaled iloprost suppresses the cardinal features of asthma via inhibition of airway dendritic cell function.NK cells are negatively regulated by sCD83 in experimental autoimmune uveitis Targeting CD83 for the treatment of graft-versus-host disease.Dexamethasone/1alpha-25-dihydroxyvitamin D3-treated dendritic cells suppress colitis in the SCID T-cell transfer model.Involvement of Caveolin-1 in CD83 Internalization in Mouse Dendritic Cells.NFATc1 deficiency in T cells protects mice from experimental autoimmune encephalomyelitis.Increased levels of circulating soluble CD14 but not CD83 in infants are associated with early intestinal colonization with Staphylococcus aureus.Tolerogenic Transcriptional Signatures of Steady-State and Pathogen-Induced Dendritic Cells.An Expanded Neuroimmunomodulation Axis: sCD83-Indoleamine 2,3-Dioxygenase—Kynurenine Pathway and Updates of Kynurenine Pathway in Neurologic Diseases.

P2860

Q30317628-BAC4B8E6-7D86-4696-A16D-692901AC5750 Q33279528-599A385E-41AA-48EB-BAB7-512DF4C47556 Q33294726-CD455888-9D06-488B-AE8E-734317FB46F5 Q33489629-6BF4C9D1-8FF2-4A61-9F9F-CF57EB316077 Q33603244-B46BE4A8-2877-4D0A-9AD5-6AC594C431E4 Q34157221-EEB0049E-3895-4EA2-A80E-B540BF43EF2A Q34501441-9C09B935-DFF7-4DDB-BC24-70941BFA6BCC Q34989042-0357E4E4-2857-4248-921B-323773C0B2CD Q35080739-402C74B0-D3E9-47A6-A50A-29D07595467B Q35106954-F31DA847-7302-4004-95BE-116A13127FEA Q35558734-D7E46E8A-68FC-4EBA-A56F-2A6F1E01E8E6 Q35756936-1A6549E4-D72B-4B46-898E-04A60CC37F9B Q36317146-1E2C484F-9D4D-41B1-8C14-D472D8F50851 Q36836259-211A34BB-E94E-4214-A917-B22671CAFFC4 Q37000947-6DCD3B71-E257-4248-A34B-A68983BDF4B1 Q37176537-C5E7DF0B-4211-4AD2-8216-159AC70C0550 Q37197974-939DA255-729F-4CE0-8A4B-E9D76D5E9BAE Q37242298-311E425D-ECEB-4C63-9A5A-377B94001FF6 Q37368494-2412A508-9E55-4C48-8424-30585EC3D108 Q37681536-A32F128F-F114-4A1A-A12D-5D2489EBADE3 Q39790735-50209619-559E-44B9-8A67-53F6B2A3B618 Q39897656-B01714F7-6325-4668-A86E-DF8A5EED8F8B Q40146699-897BDACA-6070-498D-B3C2-8A78B38ACBF7 Q40189763-5DF05182-5E7F-4190-AE74-E1B4A044D3C7 Q40224289-486D9E43-DB82-4D06-830D-8B3061404622 Q40331128-5315E9EB-4C8F-46E2-84B9-97B4CCF885F1 Q40752721-62C14B52-1DFB-4B41-837C-1A4487851777 Q41263643-C1415871-474C-4402-89BA-F6FD517F5D81 Q41431895-27A632F3-2D68-4B6C-8E9F-2DA38B647A97 Q41872741-BB3FC7C9-6AF6-49B3-9986-37999B83BC2F Q42143566-ADA68E0F-8658-43DA-A16B-82AB05F747C8 Q42378981-294B7BFC-ABF0-4363-B4E2-B503D7B3466F Q43104684-FD60FE61-A677-4399-95A4-84365B94DDDE Q43824130-7ECF2C4B-8C74-4AAE-8AA8-1708030F91D5 Q46752549-4CE2D569-EA3F-426B-B743-B28E121EFC8B Q48324271-768039CB-56E1-4A22-8CC7-3B3360479D83 Q50774855-FE01100A-6915-4443-9294-0370E6CC8098 Q54255767-8C3057FF-55ED-4212-A9D1-8FA896510362 Q55381445-CB2F6ECC-9E96-479C-AF3F-CB08F301FB13

P2860

Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83

http://www.wikidata.org/entity/Q36399744

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83

@ast

Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83

@en

type

label

Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83

@ast

Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83

@en

prefLabel

Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83

@ast

Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83

@en

P1433

Q36399744-A3629ED9-DF75-4548-AD55-E0151E64D419

P1476

Q36399744-A922245E-3D06-47FE-9295-E4A46A66F623

P2093

Q36399744-039B8CF8-029F-4297-A284-3219D090E292

Q36399744-3003C32A-48DF-4731-A264-4C09A5965266

Q36399744-850DA910-051F-4016-86DA-E8929AC570B1

Q36399744-940DA48F-B0FB-4E10-9713-503FB0470A33

Q36399744-AC1C3E95-9933-4993-9629-D1E1272F0636

P2860

Q36399744-011B4D93-E58C-47A8-B3A7-6589962FEE63

Q36399744-02BE4734-7051-4D45-8408-FE1FD7085965

Q36399744-08330463-4657-4E5D-9040-28D267E3157F

Q36399744-18FEBB68-926E-4DFD-A102-B98C6E913E8C

Q36399744-2E345400-F8AF-445F-9001-906A16C4A9A8

Q36399744-5B97F933-1A83-49E2-B34C-11FD1F300902

Q36399744-6FA7BABF-B80C-4C03-9282-5CE898EC4213

Q36399744-7975AF67-B958-4330-B613-A699CE19BF98

Q36399744-83F9B930-BDCC-4A4A-8449-F3DA99F00B59

Q36399744-97E332E7-BBBF-49D4-98A6-724223B586B3

P304

Q36399744-F1411214-6136-4C36-AACF-364D6EF596F2

P31

Q36399744-A0682452-08A3-46D2-81BA-4F30EA8197B1

P356

Q36399744-1A0A3B2C-235C-45A3-B401-0DBB25F087E9

P407

Q36399744-846BD2D7-6CDE-462D-A039-DF2AFE5538B0

P433

Q36399744-33A719A7-EF9D-4701-81A8-198377F15754

P478

Q36399744-5618622E-3D0E-4B10-8635-B6C2802CCCD2

P577

Q36399744-8FEF6C42-89D9-4268-A4A7-F294D6E10955

P5875

Q36399744-18B7237E-9796-473E-A3A7-2AD7779C5460

P698

Q36399744-9BDBC0D1-1012-4016-945B-F628AEFE0D15

P921

Q36399744-1DC41E3F-512F-4457-915E-39AA0F912A32

P932

Q36399744-9E525CCA-8EFE-45EA-B2AB-D94FBA5E0D9E

P356

P1433

Journal of Experimental Medicine

P1476

Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83

@en

P2093

Alexander Steinkasserer

http://www.w3.org/2001/XMLSchema#string

Antje Golka

http://www.w3.org/2001/XMLSchema#string

Elisabeth Zinser

http://www.w3.org/2001/XMLSchema#string

Manfred B Lutz

http://www.w3.org/2001/XMLSchema#string

Matthias Lechmann

http://www.w3.org/2001/XMLSchema#string

P2860

A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily

Subtractive cDNA cloning of a novel member of the Ig gene superfamily expressed at high levels in activated B lymphocytes

Dendritic cells and the control of immunity

Immunobiology of dendritic cells

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

The dendritic cell system and its role in immunogenicity

Cloning, recombinant expression and biochemical characterization of the murine CD83 molecule which is specifically upregulated during dendritic cell maturation.

CD83 on dendritic cells: more than just a marker for maturation.

The soluble form of CD83 is present at elevated levels in a number of hematological malignancies.

The mouse Cd83 gene: structure, domain organization, and chromosome localization.

P304

345-351

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20030973

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

200

http://www.w3.org/2001/XMLSchema#string

P577

2004-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8420059

http://www.w3.org/2001/XMLSchema#string

P698

15289503

http://www.w3.org/2001/XMLSchema#string

P921

experimental autoimmune encephalomyelitis

P932

2211980

http://www.w3.org/2001/XMLSchema#string